FOR IMMEDIATE RELEASE
Date September 6, 2017
MORRISTOWN, NJ, RxC International, a premier life sciences management consulting firm, announced today that Bradley K. Kozar has joined the firm as a Strategy Partner. Brad is a payer strategy and market access consulting executive with significant consulting/agency and pharmaceutical industry experience. “Brad is a leading expert in managed markets - he has led many successful biopharma product launches and has been instrumental in helping his clients achieve more favorable market access through better formulary placement and reimbursement. We are excited to have Brad joining us to provide our clients with a more integrated offering by addressing market access within our core services of corporate strategy, new product strategy and commercial excellence,” said Subbarao Jayanthi, Managing Partner of RxC International.
Prior to joining RxC International, Brad founded MediMedia Managed Markets, LLC, which he led for 16 years before a successful divestiture of the company (now owned by ICON plc). Brad successfully leveraged his extensive strategy consulting experience at Charles River Associates where he served as a payer strategist and at NucleusX where he served as Global Head of Market Access and HEOR. Brad also gained significant biopharma industry experience early in his career at Marion Labs and Ortho Biotech/Johnson & Johnson.
Brad has deep expertise across multiple therapeutic areas including biologics, oncology, and specialty products, as well as a strong understanding of current and evolving healthcare delivery models including Commercial Managed Care, Pharmacy Benefit Managers (PBMs), Government (i.e. Medicare Part D, Medicaid, VAs/Tricare), Accountable Care Organizations (ACOs), Health Exchanges, Long Term Care/Home Health, and Employers.
Throughout his career, Brad was instrumental to the success of a number of blockbuster drugs and biopharmaceutical/specialty products while ensuring the highest level of client focus and satisfaction. “I’m very excited about joining RxC International to add market access to their expertise and provide clients with a more complete suite of critically important services. Following product approval, market access and reimbursement often are the most important determinants of product uptake, revenue, and life cycle success,” said Kozar.
Brad serves on boards for several nonprofit organizations, has served on the Industry Advisory Board of the Academy of Managed Care Pharmacy (AMCP), and has frequently been a speaker at conferences on managed care and market access. He has moderated more than 800 customer policy, research, and advisory board meetings as well as served as a panel moderator and trainer.
Brad holds a degree in Communication from the University of Toledo, where he has continued his involvement as a member of the Alumni Board of Trustees and other committees within the university campus (which includes a Medical School, Pharmacy School, Business School, etc.).
ABOUT RXC INTERNATIONAL
RxC International is a premier life sciences management consulting firm. RxC collaborates with clients to identify and develop growth opportunities. The firm leverages consulting partners and advisers to combine strategic and operational expertise to bring multiple perspectives to every engagement. The firm has deep expertise in corporate strategy, new product strategy, and commercial excellence. Clients include leading pharmaceutical, biotechnology, and medical technology companies around the world. The firm also supports private equity and venture capital firms on strategic transactions. The firm’s corporate headquarters is located in Morristown, New Jersey, and it has offices in Massachusetts and California. Additional information about RxC International can be found at www.RxCInternational.com.
Frank Koos, 855-792-7920